The UK Ophthalmic Drugs Market growth continues to expand as regulatory bodies streamline approval pathways and reimbursement processes for innovative eye therapies. With ophthalmic drugs representing one of the highest-value therapeutic categories in the NHS, the urgency for cost-effective innovations has never been greater. Rising demand for intravitreal injections, increasing specialist...